Safety and Efficacy of Fimasartan in Mexican Patients With Grade 1–2 Essential Hypertension

Archivos de Cardiologia de Mexico - Mexico
doi 10.1016/j.acmx.2017.01.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publicidad Permanyer, SLU

Related search

E0352 Efficacy and Safety of Aliskiren in Chinese Patients With Mild or Moderate Essential Hypertension

Heart
Cardiovascular MedicineCardiology
2010English

Safety and Efficacy of Eplerenone in the Management of Essential Hypertension

Clinical Medicine. Therapeutics
2009English

Use of Amelotex to Treat Patients With Acute Musculoskeletal Pain in the Back and Grade 1 Essential Hypertension

Nevrologiya, Neiropsikhiatriya, Psikhosomatika
PsychiatryClinical PsychologyMental HealthNeurology
2011English

Efficacy and Safety of Imarikiren in Patients With Type 2 Diabetes and Microalbuminuria

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2019English

Safety and Efficacy of Oral Anticoagulation Therapy in Chinese Patients With Concomitant Atrial Fibrillation and Hypertension

Journal of Human Hypertension
Internal Medicine
2010English

A Randomized Comparison Between Lercanidipine and Amlodipine for Efficacy and Tolerability in Patients With Essential Hypertension

International Journal of Basic and Clinical Pharmacology
2016English

Impact of Qigong Exercise on Self-Efficacy and Other Cognitive Perceptual Variables in Patients With Essential Hypertension

Journal of Alternative and Complementary Medicine
Alternative MedicineComplementary
2004English

Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Influence of Additional Risk Factors on the Antihypertensive Efficacy of Eprosartan and Telmisartan in Patients With Essential Hypertension

Pathologia
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy